Chemical Structure : BTSA1.2
货号: PC-72943Not For Human Use, Lab Use Only.
BTSA1.2 is a potent, selective, orally bioavailable BAX activator, demonstrated increased binding to BAX (IC50=149 nM) compared to BTSA1 (IC50=247 nM).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BTSA1.2 is a potent, selective, orally bioavailable BAX activator, demonstrated increased binding to BAX (IC50=149 nM) compared to BTSA1 (IC50=247 nM).
BTSA1.2 also showed more potent cellular activity in a set of lymphoma cell lines compared to BTSA1(SU-DHL-4 IC50 1.24 uM vs2.29 uM, SU-DHL-6 IC50 1.75 uM vs2.6 uM).
BTSA1.2 directly engaging with cellular BAX.
BTSA1.2 demonstrated favorable properties by oral administration such as substantial half-life (T1/2 ~14 h) in mouse plasma, favorable oral bioavailability (%F ~50%) and significant plasma exposure (AUC-100 uΜ h).
BTSA1.2 treatment showed significantly better cytotoxicity in leukemia and lymphoma cell lines (mean IC50<3 uM) than in most solid tumor cell lines (mean IC50>10 uM).
BTSA1.2 and Navitoclax synergize to inhibit cell viability and induce apoptosis in various tumor cell lines.
Combination of BTSA1.2 and Navitoclax is well tolerated and does not enhance Navitoclax driven toxicity in the hematopoietic system, shows potent efficacy in resistant colorectal tumor xenografts.
BTSA1.2, a rationalized BTSA1 analog, has improved binding to BAX, cellular cytotoxicity, and is better-tolerated in vivo.
分子量 | 458.558 | |
分子式 | C23H18N6OS2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Andrea Lopez, et al. Nat Commun. 2022 Mar 7;13(1):1199.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright